UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Rucaparib in Men With Metastatic Castration-Resistant Prostate Cancer Harboring a BRCA1 or BRCA2 Gene Alteration

Journal of clinical oncology, 2020-11, Vol.38 (32), p.3763-3772

2020

Link zum Volltext

Verfügbarkeit prüfen

Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer

The New England journal of medicine, 2018-04, Vol.378 (15), p.1408-1418

2018

Link zum Volltext

Verfügbarkeit prüfen

Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer

The New England journal of medicine, 2019-07, Vol.381 (1), p.13-24

2019

Link zum Volltext

Verfügbarkeit prüfen

Response Rate to Chemotherapy After Immune Checkpoint Inhibition in Metastatic Urothelial Cancer

European urology, 2018-02, Vol.73 (2), p.149-152

2018

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of enzalutamide versus bicalutamide for patients with metastatic prostate cancer (TERRAIN): a randomised, double-blind, phase 2 study

The lancet oncology, 2016-02, Vol.17 (2), p.153-163

2016

Link zum Volltext

Verfügbarkeit prüfen

Genomic landscape of platinum resistant and sensitive testicular cancers

Nature communications, 2020-05, Vol.11 (1), p.2189-2189, Article 2189

2020

Link zum Volltext

Verfügbarkeit prüfen

Systematic Review and Meta-Analysis of Correlation of Progression-Free Survival-2 and Overall Survival in Solid Tumors

Frontiers in oncology, 2020-08, Vol.10, p.1349-1349

2020

Link zum Volltext

Verfügbarkeit prüfen

Combination of Anti-Angiogenics and Checkpoint Inhibitors for Renal Cell Carcinoma: Is the Whole Greater Than the Sum of Its Parts?

Cancers, 2022-01, Vol.14 (3), p.644

2022

Link zum Volltext

Verfügbarkeit prüfen

Sequential FDG-PET/CT as a Biomarker of Response to Sunitinib in Metastatic Clear Cell Renal Cancer

Clinical cancer research, 2011-09, Vol.17 (18), p.6021-6028

2011

Link zum Volltext

Verfügbarkeit prüfen

Treatment landscape and burden of disease in metastatic castration-resistant prostate cancer: systematic and structured literature reviews

Frontiers in oncology, 2023-09, Vol.13, p.1240864-1240864

2023

Link zum Volltext

Verfügbarkeit prüfen

HER2 Mediates PSMA/mGluR1-Driven Resistance to the DS-7423 Dual PI3K/mTOR Inhibitor in PTEN Wild-type Prostate Cancer Models

Molecular cancer therapeutics, 2022-04, Vol.21 (4), p.667-676

2022

Link zum Volltext

Verfügbarkeit prüfen

Matching-Adjusted Indirect Comparison of Health-Related Quality of Life and Adverse Events of Apalutamide Versus Enzalutamide in Non-Metastatic Castration-Resistant Prostate Cancer

Advances in therapy, 2020-01, Vol.37 (1), p.512-526

2020

Link zum Volltext

Verfügbarkeit prüfen

Real-World Outcomes in First-Line Treatment of Metastatic Castration-Resistant Prostate Cancer: The Prostate Cancer Registry

Targeted oncology, 2020-06, Vol.15 (3), p.301-315

2020

Link zum Volltext

Verfügbarkeit prüfen

PARP inhibitors and stratified treatment of prostate cancer

Expert review of anticancer therapy, 2016-12, Vol.16 (12), p.1213-1215

2016

Link zum Volltext

Verfügbarkeit prüfen

ATLANTIS: a randomised multi-arm phase II biomarker-directed umbrella screening trial of maintenance targeted therapy after chemotherapy in patients with advanced or metastatic urothelial cancer

Trials, 2020-04, Vol.21 (1), p.344-344, Article 344

2020

Link zum Volltext

Verfügbarkeit prüfen

Apalutamide for metastatic castration-sensitive prostate cancer: final analysis of the Asian subpopulation in the TITAN trial

Asian journal of andrology, 2023-11, Vol.25 (6), p.653-661

2023

Link zum Volltext

Verfügbarkeit prüfen

Accurate prostate cancer detection based on enrichment and characterization of prostate cancer specific circulating tumor cells

Cancer medicine (Malden, MA), 2023-04, Vol.12 (8), p.9116-9127

2023

Link zum Volltext

Verfügbarkeit prüfen

Recent advances in the treatment of renal cell carcinoma and the role of targeted therapies

European journal of cancer (1990), 2008-10, Vol.44 (15), p.2152-2161

2008

Link zum Volltext

Verfügbarkeit prüfen

Real-world Treatment Sequencing in Patients with Metastatic Castration-resistant Prostate Cancer: Results from the Prospective, International, Observational Prostate Cancer Registry

European urology open science (Online), 2022-11, Vol.45, p.12-22

2022

Link zum Volltext

Verfügbarkeit prüfen

Reply to Feng Qi, Zicheng Xu, and Qing Zou’s Letter to the Editor re: Andrea Loehr, Arif Hussain, Akash Patnaik, et al. Emergence of BRCA Reversion Mutations in Patients with Metastatic Castration-resistant Prostate Cancer After Treatment with Rucaparib. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.09.010

European urology, 2023-03, Vol.83 (3), p.e78-e78

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 551

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(507)
Mit Volltextzugriff
(494)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(334)
Life Sciences & Biomedicine
(284)
Humans
(229)
Male
(157)
Oncology
(107)
Female
(82)
Middle Aged
(80)
Aged
(79)
Prostate Cancer
(56)
Adult
(50)
Urology & Nephrology
(49)
Metastasis
(48)
Patients
(44)
Treatment Outcome
(44)
Aged, 80 And Over
(40)
Physical Sciences
(39)
Prostatic Neoplasms, Castration-Resistant - Drug Therapy
(39)
Metastases
(34)
Antineoplastic Agents - Therapeutic Use
(33)
Clinical Trials
(32)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Rucaparib in Men With Metastatic Castration-Resistant Prostate Cancer Harboring a BRCA1 or BRCA2 Gene Alteration

Non-BRCA DNA Damage Repair Gene Alterations and Response to the PARP Inhibitor Rucaparib in Metastatic Castration-Resistant Prostate Cancer: Analysis From the Phase II TRITON2 Study

Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer

Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer

Response Rate to Chemotherapy After Immune Checkpoint Inhibition in Metastatic Urothelial Cancer

Efficacy and safety of enzalutamide versus bicalutamide for patients with metastatic prostate cancer (TERRAIN): a randomised, double-blind, phase 2 study

Comparative effectiveness of gemcitabine plus cisplatin versus methotrexate, vinblastine, doxorubicin, plus cisplatin as neoadjuvant therapy for muscle‐invasive bladder cancer

Effect of enzalutamide on health-related quality of life, pain, and skeletal-related events in asymptomatic and minimally symptomatic, chemotherapy-naive patients with metastatic castration-resistant prostate cancer (PREVAIL): results from a randomised, phase 3 trial

Genomic landscape of platinum resistant and sensitive testicular cancers

Systematic Review and Meta-Analysis of Correlation of Progression-Free Survival-2 and Overall Survival in Solid Tumors

Combination of Anti-Angiogenics and Checkpoint Inhibitors for Renal Cell Carcinoma: Is the Whole Greater Than the Sum of Its Parts?

Sequential FDG-PET/CT as a Biomarker of Response to Sunitinib in Metastatic Clear Cell Renal Cancer

Treatment landscape and burden of disease in metastatic castration-resistant prostate cancer: systematic and structured literature reviews

HER2 Mediates PSMA/mGluR1-Driven Resistance to the DS-7423 Dual PI3K/mTOR Inhibitor in PTEN Wild-type Prostate Cancer Models

Matching-Adjusted Indirect Comparison of Health-Related Quality of Life and Adverse Events of Apalutamide Versus Enzalutamide in Non-Metastatic Castration-Resistant Prostate Cancer

Real-World Outcomes in First-Line Treatment of Metastatic Castration-Resistant Prostate Cancer: The Prostate Cancer Registry

PARP inhibitors and stratified treatment of prostate cancer

ATLANTIS: a randomised multi-arm phase II biomarker-directed umbrella screening trial of maintenance targeted therapy after chemotherapy in patients with advanced or metastatic urothelial cancer

Safety and Efficacy of Pazopanib Therapy Prior to Planned Nephrectomy in Metastatic Clear Cell Renal Cancer

Apalutamide for metastatic castration-sensitive prostate cancer: final analysis of the Asian subpopulation in the TITAN trial

Accurate prostate cancer detection based on enrichment and characterization of prostate cancer specific circulating tumor cells

Recent advances in the treatment of renal cell carcinoma and the role of targeted therapies

Real-world Treatment Sequencing in Patients with Metastatic Castration-resistant Prostate Cancer: Results from the Prospective, International, Observational Prostate Cancer Registry

Localising occult prostate cancer metastasis with advanced imaging techniques (LOCATE trial): a prospective cohort, observational diagnostic accuracy trial investigating whole-body magnetic resonance imaging in radio-recurrent prostate cancer

Suchergebnisse filtern